Buy Narcis Stack For Sale (YK-11 + Cardarine + MK-677) – Product Details

Narcis Stack consists of YK-11, Cardarine and MK-677

• Tablets is offered in 2 variants: 25mg Cardarine, 13mg YK-11 and 25mg MK677, totaling 63mg per tablet for 20 tablets or 1250mg in total; and 25mg Cardarine, 13mg YK-11 and 25mg MK677, totaling 63mg per tablet for 40 tablets or 2500mg in total.
• Liquid is offered in 100mg per ml for 30ml, totaling 3000ml.

YK-11

A recent study has shown that YK11, a selective androgen receptor myostatin inhibitor, accelerates the expression of Follistatin in mice. Follistatin is a myostatin and activin-binding protein naturally found in the human body and has been used as a treatment for several degenerative muscle diseases. When follistatin levels are raised, myostatin levels will be inhibited. Inhibition of myostatin results in increased muscle mass and improved strength.

This study revealed that mice with low levels of myostatin have twice the amount of muscle mass compared to mice with high levels of myostatin. This shows the massive potential research implications of the strong anabolic effects that YK-11 can possess.

Cardarine

GW-501516, also known as Cardarine, is a PPAR agonist. Cardarine is used in research for its potential to facilitate fat-burning by increasing endurance and stamina. A study done on the effects of GW-501516 for enhancing running endurance in Kunming mice demonstrated that a 3-week dosing protocol with GW501516 was able to increase performance related to running of both trained and untrained mice. Similar to training, GW501516 showed an increase in mitochondrial fatty acid oxidation and enhanced fat metabolism in muscle tissue. This could potentially lead to less demanding cardiovascular work, increasing weekly deficits, resulting in increased fat loss.

MK-677

A recent study set out to investigate the effects of MK-677 as a Ghrelin mimetic on body composition and clinical outcomes in healthy older adults. It was found that MK-677 enhanced fluctuating growth hormone secretion and markedly increased fat free mass over a 12-month period. More extensive research and randomized trials could potentially evaluate its efficacy in improving physical function and health outcomes in select populations.